-
Healthcare Resource U tilization and Healthcare Costs After Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy in the United States: The ENDURE Study
Mar 10, 2025, 14:00 PM -
Comparison of an Innovative Static Model With Dynamic Adjustment With a Dynamic Model To Assess the Public Health Impact of TAK-003 Vaccination: Case Studies in Thailand and Brazil
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization and Costs in Patients with Itch-Dominant Moderate-to-Severe Atopic Dermatitis Treated in Private Dermatology Facilities in the United States
Mar 10, 2025, 14:00 PM -
Leveraging Consumer-Grade Wearables in Clinical Trials: Insights From Digital Primary Endpoints
Mar 10, 2025, 14:00 PM -
The Burden of Prader-Willi Syndrome on Patients and the Healthcare System: A cross-Sectional Examination of Emergency Department Visits and Inpatient Stays in US claims
Mar 10, 2025, 14:00 PM -
Characterizing Social Determinants of Health in the Population Receiving Respiratory Syncytial Virus Vaccination in a Nationwide Pharmacy Chain in the United States
Mar 10, 2025, 14:00 PM -
From Data to Decisions: The Role of Real-World Evidence in Recent Multiple Myeloma Drug Approvals in the US and EU
Mar 10, 2025, 14:00 PM -
Pharmacometric-Pharmacoeconomic Modeling and Simulation to Assess Target Product Profile Characteristics in Early Drug Development: Application to Atopic Dermatitis
Mar 10, 2025, 14:00 PM -
A Targeted Literature Review of Patient Perspectives of Placebo Use in Clinical Trials: How Can the Patient Voice Help Drug Developers in Trial Design, Recruitment, and Retention?
Mar 10, 2025, 14:00 PM -
An Overview of the Patient Journey and Treatment Utilization in Patients With Prurigo Nodularis
Mar 10, 2025, 14:00 PM -
Efficiency Benefits and Practice Value of Alcon's Digital Cataract Surgery Planning System
Mar 10, 2025, 14:00 PM -
Challenges for PAIC in Rare Diseases: Results of a Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Real-World Evidence of Setmelanotide in Patients with Rare Melanocortin-4 Receptor Pathway Diseases: Baseline Findings from the RESTORE Longitudinal Survey Study
Mar 10, 2025, 14:00 PM -
Burden of Administration: Belamaf Based Combinations (BVd, BPd) Versus Carfilzomib Based Combinations (IsaKd, DKd, Kd)
Mar 10, 2025, 14:00 PM -
Characteristics of Patients With Bullous Pemphigoid in the US Medicare Population
Mar 10, 2025, 14:00 PM -
Characteristics of Patients Initiating Glucagon-like Peptide-1 (GLP-1) Receptor Agonists (RAs) for Cardiometabolic Risk Reduction in a Medicare Population
Mar 10, 2025, 14:00 PM -
Characterizing Improvements in Physical Functioning with PROMIS-PF and In-Trial Exit Interviews: A Mixed-Methods Analysis to Understand the Meaningful Changes Experienced by TGCT Patients on Vimseltinib in the MOTION Trial
Mar 10, 2025, 14:00 PM -
Gut Microbiota and Inflammation in Patients Which Schizophrenia
Mar 10, 2025, 14:00 PM -
Integrating Cancer Trials Into Value-Based Care: The ‘Let Me Trial’ Model in Brazil
Mar 10, 2025, 14:00 PM -
One Size Doesn’t Fit All: Learnings from a Pilot Survey Assessing Preferences for Improvement vs Worsening of Healthcare Professionals
Mar 10, 2025, 14:00 PM